Aesthetic Medicine Market revenue to cross USD 24 Bn by 2026: Global Market Insights, Inc.
03 août 2020 06h30 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Aug. 03, 2020 (GLOBE NEWSWIRE) -- According to latest report “Aesthetic Medicine Market by Type (Surgical Procedures, Non-surgical Procedures), Product (Facial Aesthetic...
Misonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 Million
10 juil. 2020 07h00 HE
|
MISONIX, Inc.
Full Year Revenue of Approximately $62.3 Million Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies FARMINGDALE,...
Misonix Fiscal 2020 Third Quarter Revenue Rises to $17.9 Million
11 mai 2020 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Rising Airborne Disease Prevalence to Drive Surgical, Face, and Respiratory Mask Market Revenue to $15,696.2 Million by 2030: P&S Intelligence
09 avr. 2020 04h00 HE
|
Prescient & Strategic Intelligence Private Limited
NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) -- Around the world, the prevalence of airborne diseases is rising, which is creating grave concerns for public health. The most common such diseases are...
MISONIX REPORTS PRELIMINARY FISCAL 2020 THIRD QUARTER REVENUE OF APPROXIMATELY $17.9 MILLION
02 avr. 2020 10h00 HE
|
MISONIX, Inc.
With Focus on Maintaining Our Objective of Shareholder Value Creation, Company to Prioritize Cash Preservation Through Expense Reduction, Workforce Efficiency and Operational Synergies ...
Global Facial/Surgical Mask Market Observing a CAGR of 20.0% during 2020–2025: VynZ Research
24 mars 2020 09h37 HE
|
VynZ Research
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- The global facial/surgical mask market is growing at a CAGR of 20.0% during 2020-2025. The increasing air pollution, increasing prevalence of respiratory...
Misonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Second Quarter
05 févr. 2020 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
30 août 2019 09h00 HE
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical®...
ORHub, Inc. Announces a Stay of Litigation
30 août 2019 08h30 HE
|
ORHub, Inc.
TEMPE, Ariz., Aug. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – ORHub, Inc. (OTC: ORHB) ("ORHub" or the "Company"), a Microsoft Silver Partner and cloud-based healthcare intelligence company...
Misonix Reports Fourth Quarter and Fiscal Year 2019 Results
14 août 2019 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...